Formerly known as MOFAS: Minnesota Organization on Fetal Alcohol Syndrome

Exciting News
from MOFAS

If you're looking for the Minnesota Organization on Fetal Alcohol Syndrome (MOFAS) you have come to the right place. We have some exciting news about our organization. We have a new name! MOFAS has officially been renamed Proof Alliance. Our mission remains the same: to prevent prenatal alcohol exposure and to improve the quality of life for people living with fetal alcohol spectrum disorders (FASD).

Why PR%F

We now have the proof that prenatal alcohol exposure is a leading cause of brain injury in children. We have the proof that FASD is 100% preventable and people living with an FASD can reach 100% of their potential.

Why Alliance?

We seek to build powerful alliances with people with an FASD, their families, legislators, experts in the field, new partners, and community members to bring awareness, research, and services to this field.

What's Next?

Proof Alliance is rebranding, expanding, and we're moving! We have a new logo, website, and prevention campaign to help change the norms around drinking during pregnancy. And in May 2019 we will be moving to a stand-alone building. Proof Alliance commits to the people of Minnesota and we will continue to develop transformative programs to help Minnesotans impacted by FASD.

Participants Needed for FASD Clinical Trial

May 31, 2016

The University of Minnesota is currently conducting two research studies on prenatal alcohol exposure (PAE) / Fetal Alcohol Spectrum Disorders (FASD) and needs families to participate. There are two studies:

  1. A study taking place in conjunction with 4 sites around the country that is looking at brain and cognitive development in children with FASD. This study involves neuropsychological testing and questionnaires during one visit. It pays $70 for time and it covers mileage, parking, etc. For this study, we need children under the age of 8 years old.
  1. A treatment study in which children ages 2 to 5 years old are given an experimental treatment (choline, a nutrient) or placebo for 9 months.  The goal is to determine if choline improves cognitive functioning, especially in the area of memory and executive functioning.  Because this study is a clinical trial, it does not involve payment for participation.  However, mileage, parking, and all other expenses are covered by the study.

If you are a parent/caregiver with a child who has had prenatal alcohol exposure, please contact the U of M if you are interested in helping by participating in the study at 612-624-0195 or

FASD clinical trial2

Click brochure for more information.

Share this page:

Support &

Women &

Training &